Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer

Simona Coco, Silvia Bonfiglio, Davide Cittaro, Irene Vanni, Marco Mora, Carlo Genova, Maria Giovanna Dal Bello, Simona Boccardo, Angela Alama, Erika Rijavec, Claudio Sini, Valeria Rossella, Giulia Barletta, Federica Biello, Anna Truini, Cristina Bruzzo, Maurizio Gallo, Dejan Lazarevic, Alberto Ballestrero, Francesco Grossi

Research output: Contribution to journalArticle

Abstract

Women treated for breast cancer (BC) are at risk of developing secondary tumors, such as lung cancer (LC). Since rare germline variants have been linked to multiple cancer development, we hypothesized that BC survivors might be prone to develop LC as a result of harboring rare variants. Sixty patients with LC with previous BC (the study population; SP) and 53 women with either BC or LC and no secondary cancer (control population; CP) were enrolled. Whole exome sequencing was performed in both tumors and unaffected tissues from28/60 SP patients, and in germline DNA from 32/53 CP. Candidate genes were validated in the remaining individuals from both populations. We found two main mutational signature profiles: S1 (C>T) in all BCs and16/28 LCs, and S2 (C>A) which is strongly associated with smoking, in12/28 LCs. The burden test over rare germline variants in S1-LC vs CP identified248 genes. Validation confirmed GSN as significantly associated with LC in never-smokers. In conclusion, our data suggest two signatures involved in LC onset in women with previous BC. One of these signatures is linked to smoking. Conversely, regardless of smoking habit, in a subgroup of BC survivors genetic susceptibility may contribute to LC risk

Original languageEnglish
Article number441
JournalCancers
Volume11
Issue number4
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Exome
Lung Neoplasms
Breast Neoplasms
Smoking
Survivors
Neoplasms
Population
Genetic Predisposition to Disease
Genes
Habits

Keywords

  • Breast cancer
  • Exome sequencing
  • Genetic predisposition
  • Lung cancer
  • Multiple cancer susceptibility

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer. / Coco, Simona; Bonfiglio, Silvia; Cittaro, Davide; Vanni, Irene; Mora, Marco; Genova, Carlo; Bello, Maria Giovanna Dal; Boccardo, Simona; Alama, Angela; Rijavec, Erika; Sini, Claudio; Rossella, Valeria; Barletta, Giulia; Biello, Federica; Truini, Anna; Bruzzo, Cristina; Gallo, Maurizio; Lazarevic, Dejan; Ballestrero, Alberto; Grossi, Francesco.

In: Cancers, Vol. 11, No. 4, 441, 01.04.2019.

Research output: Contribution to journalArticle

Coco, S, Bonfiglio, S, Cittaro, D, Vanni, I, Mora, M, Genova, C, Bello, MGD, Boccardo, S, Alama, A, Rijavec, E, Sini, C, Rossella, V, Barletta, G, Biello, F, Truini, A, Bruzzo, C, Gallo, M, Lazarevic, D, Ballestrero, A & Grossi, F 2019, 'Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer', Cancers, vol. 11, no. 4, 441. https://doi.org/10.3390/cancers11040441
Coco, Simona ; Bonfiglio, Silvia ; Cittaro, Davide ; Vanni, Irene ; Mora, Marco ; Genova, Carlo ; Bello, Maria Giovanna Dal ; Boccardo, Simona ; Alama, Angela ; Rijavec, Erika ; Sini, Claudio ; Rossella, Valeria ; Barletta, Giulia ; Biello, Federica ; Truini, Anna ; Bruzzo, Cristina ; Gallo, Maurizio ; Lazarevic, Dejan ; Ballestrero, Alberto ; Grossi, Francesco. / Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer. In: Cancers. 2019 ; Vol. 11, No. 4.
@article{7ad65d9d51d04b34882fcd8b151db238,
title = "Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer",
abstract = "Women treated for breast cancer (BC) are at risk of developing secondary tumors, such as lung cancer (LC). Since rare germline variants have been linked to multiple cancer development, we hypothesized that BC survivors might be prone to develop LC as a result of harboring rare variants. Sixty patients with LC with previous BC (the study population; SP) and 53 women with either BC or LC and no secondary cancer (control population; CP) were enrolled. Whole exome sequencing was performed in both tumors and unaffected tissues from28/60 SP patients, and in germline DNA from 32/53 CP. Candidate genes were validated in the remaining individuals from both populations. We found two main mutational signature profiles: S1 (C>T) in all BCs and16/28 LCs, and S2 (C>A) which is strongly associated with smoking, in12/28 LCs. The burden test over rare germline variants in S1-LC vs CP identified248 genes. Validation confirmed GSN as significantly associated with LC in never-smokers. In conclusion, our data suggest two signatures involved in LC onset in women with previous BC. One of these signatures is linked to smoking. Conversely, regardless of smoking habit, in a subgroup of BC survivors genetic susceptibility may contribute to LC risk",
keywords = "Breast cancer, Exome sequencing, Genetic predisposition, Lung cancer, Multiple cancer susceptibility",
author = "Simona Coco and Silvia Bonfiglio and Davide Cittaro and Irene Vanni and Marco Mora and Carlo Genova and Bello, {Maria Giovanna Dal} and Simona Boccardo and Angela Alama and Erika Rijavec and Claudio Sini and Valeria Rossella and Giulia Barletta and Federica Biello and Anna Truini and Cristina Bruzzo and Maurizio Gallo and Dejan Lazarevic and Alberto Ballestrero and Francesco Grossi",
year = "2019",
month = "4",
day = "1",
doi = "10.3390/cancers11040441",
language = "English",
volume = "11",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI AG",
number = "4",

}

TY - JOUR

T1 - Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer

AU - Coco, Simona

AU - Bonfiglio, Silvia

AU - Cittaro, Davide

AU - Vanni, Irene

AU - Mora, Marco

AU - Genova, Carlo

AU - Bello, Maria Giovanna Dal

AU - Boccardo, Simona

AU - Alama, Angela

AU - Rijavec, Erika

AU - Sini, Claudio

AU - Rossella, Valeria

AU - Barletta, Giulia

AU - Biello, Federica

AU - Truini, Anna

AU - Bruzzo, Cristina

AU - Gallo, Maurizio

AU - Lazarevic, Dejan

AU - Ballestrero, Alberto

AU - Grossi, Francesco

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Women treated for breast cancer (BC) are at risk of developing secondary tumors, such as lung cancer (LC). Since rare germline variants have been linked to multiple cancer development, we hypothesized that BC survivors might be prone to develop LC as a result of harboring rare variants. Sixty patients with LC with previous BC (the study population; SP) and 53 women with either BC or LC and no secondary cancer (control population; CP) were enrolled. Whole exome sequencing was performed in both tumors and unaffected tissues from28/60 SP patients, and in germline DNA from 32/53 CP. Candidate genes were validated in the remaining individuals from both populations. We found two main mutational signature profiles: S1 (C>T) in all BCs and16/28 LCs, and S2 (C>A) which is strongly associated with smoking, in12/28 LCs. The burden test over rare germline variants in S1-LC vs CP identified248 genes. Validation confirmed GSN as significantly associated with LC in never-smokers. In conclusion, our data suggest two signatures involved in LC onset in women with previous BC. One of these signatures is linked to smoking. Conversely, regardless of smoking habit, in a subgroup of BC survivors genetic susceptibility may contribute to LC risk

AB - Women treated for breast cancer (BC) are at risk of developing secondary tumors, such as lung cancer (LC). Since rare germline variants have been linked to multiple cancer development, we hypothesized that BC survivors might be prone to develop LC as a result of harboring rare variants. Sixty patients with LC with previous BC (the study population; SP) and 53 women with either BC or LC and no secondary cancer (control population; CP) were enrolled. Whole exome sequencing was performed in both tumors and unaffected tissues from28/60 SP patients, and in germline DNA from 32/53 CP. Candidate genes were validated in the remaining individuals from both populations. We found two main mutational signature profiles: S1 (C>T) in all BCs and16/28 LCs, and S2 (C>A) which is strongly associated with smoking, in12/28 LCs. The burden test over rare germline variants in S1-LC vs CP identified248 genes. Validation confirmed GSN as significantly associated with LC in never-smokers. In conclusion, our data suggest two signatures involved in LC onset in women with previous BC. One of these signatures is linked to smoking. Conversely, regardless of smoking habit, in a subgroup of BC survivors genetic susceptibility may contribute to LC risk

KW - Breast cancer

KW - Exome sequencing

KW - Genetic predisposition

KW - Lung cancer

KW - Multiple cancer susceptibility

UR - http://www.scopus.com/inward/record.url?scp=85065305813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065305813&partnerID=8YFLogxK

U2 - 10.3390/cancers11040441

DO - 10.3390/cancers11040441

M3 - Article

AN - SCOPUS:85065305813

VL - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 4

M1 - 441

ER -